QIAGEN powered by

Webinars and events

Loading Events

« All Events

  • This event has passed.

Integrating deeply curated omics data with APIs for biomarkers and drug-target investigation

September 14, 2023 @ 1:00 pm - 2:30 pm

If you’re a data scientist or bioinformatician working in biopharma and need extensive high-quality ‘omics data for your projects in target discovery, this training is for you. You’ll learn how to programmatically discover, retrieve, filter, aggregate and analyze ‘omics data from our extensive repositories of deeply-curated multi-omics data. You’ll learn how to leverage extensive metadata to find and combine datasets of interest, find and test signatures and perform custom analyses to reveal patterns relevant to disease.
Join us to learn how QIAGEN OmicSoft Lands API can revolutionize your data analysis workflows and help you make more informed decisions.

In this training, you’ll learn how to:
• Search for gene signatures to find datasets (e.g., gene set analysis to find matches of various related comparisons, where the result is a list of comparisons with Contrast names)
• Plot correlation of results (e.g., where the result is a scatter plot between dataset comparisons)
• Find multiple datasets with the same metadata (e.g., based on comparisons, you can define key metadata, then pull a bunch of datasets, and the result is a large table)
• Perform a meta-analysis (e.g., based on datasets, do a Wilcoxon non-parametric test, where the result is Volcano plot and list)
• Test cell specificity with custom aggregation (e.g., for hundreds of genes, calculate the % expressing, and aggregate across studies and by CellTypeGroup, where the result is a heatmap)

Details

Date: September 14, 2023
Time:
 1:00 pm - 2:30 pm
Register for event
Event Categories:
,
Event Tags:

Venue

Virtual – Americas – EST
United States

Other

Category
Discovery, Webinar
Register for event

On-demand Webinars


  • Indication expansion and drug repurposing using QIAGEN OmicSoft and Ingenuity Pathway Analysis

    Research and development for new drugs and disease treatments can be lengthy and costly. Indication expansion can help broaden the impact of a new drug that has already been through the arduous R&D process for a disease or cancer. Drug repurposing can take this concept and expand on it by looking for other diseases with similar drug target biology. The logic is if...

  • Part I: Single-cell RNA sequencing data analysis using QIAGEN CLC Genomics Workbench

    This two-part series will walk you through single-cell RNA sequencing (scRNA-seq) analysis starting with a matrix file or FASTQ files and ending with a deep understanding of key pathways, regulators and cell type signatures within your data. This session is for part I of this training. In this session, you'll learn to use QIAGEN CLC Genomics Workbench to perform se...

  • Part II: Single-cell RNA sequencing data interpretation using QIAGEN Ingenuity Pathway Analysis

    This two-part series will walk you through single-cell RNA sequencing (scRNA-seq) analysis starting with a matrix file or FASTQ files and ending with a deep understanding of key pathways, regulators and cell type signatures within your data. In this session, we'll explore how you can take your scRNA-seq differential expression results produced from QIAGEN CLC Genom...

  • Immune repertoire analysis using QIAGEN CLC Genomics Workbench

    The composition of the immune repertoire, consisting of the T cell and B cell receptors (TCR and BCR), is important for an organism's adaptive immune system and plays a pivotal role in an individual's overall health. Understanding the complex array of TCR and BCR allows for developing precision medicine and immunotherapy. Analyzing next-generation sequencing (NGS) dat...

  • Compare and contextualize your results using QIAGEN Ingenuity Pathway Analysis

    Take your QIAGEN Ingenuity Pathway Analysis (IPA) analyses to the next level by comparing them to your own analyses (different time points, treatments, cell lines, diseases and more) or to a library of over 100K precomputed datasets to find similar or opposite biological signatures. Identify key genes or entities and then explore how they are expressed across normal t...

  • Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft

    In this 90-minute training, you'll learn how to perform drug treatment, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands. Using public data from GTEx (normal tissue), GEO, cancer collections and more, you'll learn how to use Omicsoft Lands to: • Investigate a drug target or biom...